Letko, Brosseau & Associates Inc Abb Vie Inc. Transaction History

Letko, Brosseau & Associates Inc

$5.12 Billion
Q2 2024

A detailed history of Letko, Brosseau & Associates Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Letko, Brosseau & Associates Inc holds 318,834 shares of ABBV stock, worth $62.1 Million. This represents 1.07% of its overall portfolio holdings.

Number of Shares

318,834

Previous 326,729 2.42%

Holding current value

$62.1 Million

Previous $59.5 Million 8.09%

% of portfolio

1.07%

Previous 1.05%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$154.79 - $180.76 $1.22 Million - $1.43 Million	-7,895 Reduced 2.42%	318,834 $54.7 Million
Q1 2024 May 08, 2024	SELL	$159.82 - $182.1 $1.42 Million - $1.62 Million	-8,905 Reduced 2.65%	326,729 $59.5 Million
Q4 2023 Feb 12, 2024	SELL	$137.6 - $154.97 $703,136 - $791,896	-5,110 Reduced 1.5%	335,634 $52 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $339,318 - $392,811	-2,540 Reduced 0.74%	340,744 $50.8 Million
Q2 2023 Aug 10, 2023	SELL	$132.51 - $164.9 $93,419 - $116,254	-705 Reduced 0.2%	343,284 $46.3 Million
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $22.9 Million - $26.4 Million	-158,283 Reduced 31.51%	343,989 $54.8 Million
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $7.63 Million - $9.15 Million	-55,155 Reduced 9.89%	502,272 $81.2 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $5.51 Million - $6.32 Million	-41,027 Reduced 6.86%	557,427 $74.8 Million
Q2 2022 Aug 09, 2022	SELL	$137.62 - $174.96 $8.32 Million - $10.6 Million	-60,440 Reduced 9.17%	598,454 $91.7 Million
Q1 2022 May 11, 2022	SELL	$131.98 - $163.75 $5.51 Million - $6.84 Million	-41,775 Reduced 5.96%	658,894 $107 Million
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $2.41 Million - $3.05 Million	-22,455 Reduced 3.11%	700,669 $94.9 Million
Q3 2021 Nov 03, 2021	SELL	$106.4 - $120.78 $4.31 Million - $4.9 Million	-40,545 Reduced 5.31%	723,124 $78 Million
Q2 2021 Jul 29, 2021	SELL	$105.21 - $117.21 $992,656 - $1.11 Million	-9,435 Reduced 1.22%	763,669 $86 Million
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $24.5 Million - $26.9 Million	239,117 Added 44.78%	773,104 $83.7 Million
Q4 2020 Feb 05, 2021	SELL	$80.49 - $108.67 $3.43 Million - $4.63 Million	-42,640 Reduced 7.39%	533,987 $57.2 Million
Q3 2020 Nov 09, 2020	SELL	$85.91 - $100.83 $4.82 Million - $5.66 Million	-56,125 Reduced 8.87%	576,627 $50.5 Million
Q2 2020 Aug 07, 2020	SELL	$73.37 - $98.18 $2.87 Million - $3.83 Million	-39,050 Reduced 5.81%	632,752 $62.1 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $758,197 - $1.15 Million	11,755 Added 1.78%	671,802 $51.2 Million
Q4 2019 Feb 07, 2020	SELL	$72.13 - $90.25 $1.75 Million - $2.19 Million	-24,295 Reduced 3.55%	660,047 $58.4 Million
Q3 2019 Nov 05, 2019	SELL	$62.98 - $75.72 $758,279 - $911,668	-12,040 Reduced 1.73%	684,342 $51.8 Million
Q2 2019 Aug 01, 2019	SELL	$65.7 - $83.98 $1.83 Million - $2.34 Million	-27,910 Reduced 3.85%	696,382 $50.6 Million
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $12.8 Million - $15.1 Million	166,249 Added 29.79%	724,292 $58.4 Million
Q4 2018 Feb 08, 2019	SELL	$77.85 - $96.01 $512,953 - $632,609	-6,589 Reduced 1.17%	558,043 $51.4 Million
Q3 2018 Nov 08, 2018	SELL	$88.91 - $98.84 $1.51 Million - $1.68 Million	-17,010 Reduced 2.92%	564,632 $53.4 Million
Q2 2018 Aug 07, 2018	SELL	$89.78 - $106.23 $578,632 - $684,652	-6,445 Reduced 1.1%	581,642 $53.9 Million
Q1 2018 May 08, 2018	SELL	$92.01 - $123.21 $3.36 Million - $4.5 Million	-36,485 Reduced 5.84%	588,087 $55.7 Million
Q4 2017 Feb 20, 2018	SELL	$89.56 - $98.21 $1.34 Million - $1.47 Million	-14,975 Reduced 2.34%	624,572 $60.4 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $44.7 Million - $57.1 Million	639,547	639,547 $56.8 Million

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Letko, Brosseau & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Letko, Brosseau & Associates Inc with notifications on news.

Account

Letko, Brosseau & Associates Inc Abb Vie Inc. Transaction History